Clinical Trial: Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Study Status: Not yet recruiting
Recruit Status: Not yet recruiting
Study Type: Interventional




Official Title: Efficacy and Safety of Thrombopoietin In Patients With Severe and Very Severe Aplastic Anemia

Brief Summary: Efficacy and Safety of Recombinant human thrombopoietin in patients with severe aplastic anemia and very severe aplastic anemia, a randomized, double-blind, placebo-controlled, II phase, multi-center clinical research.